
     <!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Page Title Here</title>
  <meta name="description" content="Your description here">
  <link rel="icon" href="statmint_logo.jpeg" type="image/jpeg" />
  <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.0/dist/css/bootstrap.min.css" rel="stylesheet"/>
  <link href="https://unpkg.com/aos@2.3.4/dist/aos.css" rel="stylesheet"/>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600&display=swap" rel="stylesheet"/>
  <link href="styles.css" rel="stylesheet" />
  <!-- Optionally: <link href="ipos.css" rel="stylesheet" /> -->
</head>

<body>

  <!-- ✅ Header -->
  <header>
    <a href="index.html"><img src="statmint_logo.jpeg" alt="Statmint Logo"></a>
    <nav>
      <a href="index.html">Home</a>
      <a href="stocks.html">Healthcare Stocks</a>
      <a href="fda.html">FDA Approvals</a>
      <a href="ipos.html">Initial Public Offerings</a>
    </nav>
  </header>

  <!-- ✅ Hero -->
  <section class="hero" data-aos="fade-zoom-in">
    <h1 data-aos="fade-down">Recent Healthcare IPOs</h1>
    <p data-aos="fade-up">Track newly listed healthcare and biotech companies, their IPO performance, and market focus — all in one place.</p>
  </section>

  <!-- ✅ IPO Table -->
  <section class="section">
    <div class="container table-wrapper" data-aos="fade-up">
      <div class="table-responsive">
        <table class="table">
          <thead>
            <tr>
              <th>Company</th>
              <th>Ticker</th>
              <th>IPO Date</th>
              <th>Amount Raised</th>
              <th>Focus Area</th>
              <th>Summary</th>
            </tr>
          </thead>
          <tbody>
  <tr>
    <td><a href="https://www.sionnatx.com" target="_blank">Sionna Therapeutics</a></td>
    <td>SION</td>
    <td>February 7, 2025</td>
    <td>$219.2M</td>
    <td><span class="badge">Cystic fibrosis</span></td>
    <td>Develops drugs for cystic fibrosis that stabilize the CFTR protein, targeting patients who don’t respond to existing therapies.</td>
  </tr>
  <tr>
    <td><a href="https://www.aardvarktherapeutics.com" target="_blank">Aardvark Therapeutics</a></td>
    <td>AARD</td>
    <td>February 13, 2025</td>
    <td>$94.2M</td>
    <td><span class="badge">Metabolic drugs</span></td>
    <td>A biotech developing oral drugs to treat obesity and rare metabolic diseases like Prader-Willi syndrome by targeting hunger signals in the brain.</td>
  </tr>
  <tr>
    <td><a href="https://www.anbio.com" target="_blank">Anbio Biotech</a></td>
    <td>NNNN</td>
    <td>February 19, 2025</td>
    <td>$8M</td>
    <td><span class="badge">IVD diagnostics</span></td>
    <td>Makes rapid tests for diseases like COVID-19, flu, and RSV. Products are used by clinics, hospitals, and governments, especially across Asia.</td>
  </tr>
  <tr>
    <td><a href="https://www.wellgistics.com" target="_blank">Wellgistics Health</a></td>
    <td>WGRX</td>
    <td>February 21, 2025</td>
    <td>$4M</td>
    <td><span class="badge">Pharmacy tech</span></td>
    <td>Provides pharmacy logistics and inventory software, helping independent pharmacies and small providers manage supply chains.</td>
  </tr>
  <tr>
    <td><a href="https://baselmedicalgroup.com" target="_blank">Basel Medical Group</a></td>
    <td>BMGL</td>
    <td>February 25, 2025</td>
    <td>$8.82M</td>
    <td><span class="badge">Surgical clinics</span></td>
    <td>Operates clinics focused on spine and neurosurgery in Southeast Asia. Services target both local patients and medical tourists.</td>
  </tr>
  <tr>
    <td><a href="https://www.onconova.com" target="_blank">OncoNova Bio</a></td>
    <td>ONVB</td>
    <td>February 25, 2025</td>
    <td>$250M</td>
    <td><span class="badge">Oncology</span></td>
    <td>Developer of targeted small molecules for resistant solid tumors, expanding Phase II trials post-IPO.</td>
  </tr>
  <tr>
    <td><a href="https://www.advancedbiomed.com" target="_blank">Advanced Biomed</a></td>
    <td>ADVB</td>
    <td>March 6, 2025</td>
    <td>$6.6M</td>
    <td><span class="badge">Oncology diagnostics</span></td>
    <td>Builds microfluidic chips for early-stage cancer detection. These are cheap, small, and designed for fast testing without major lab infrastructure.</td>
  </tr>
  <tr>
    <td><a href="https://www.immunonext.com" target="_blank">ImmunoNext Inc.</a></td>
    <td>IMNX</td>
    <td>March 10, 2025</td>
    <td>$300M</td>
    <td><span class="badge">Immuno-oncology</span></td>
    <td>Emerging player in T-cell therapies for difficult-to-treat cancers, using novel bispecific antibodies.</td>
  </tr>
  <tr>
    <td><a href="https://neurosparkhealth.com" target="_blank">NeuroSpark Health</a></td>
    <td>NSPK</td>
    <td>April 5, 2025</td>
    <td>$120M</td>
    <td><span class="badge">Neurology</span></td>
    <td>Focused on neurodegenerative diseases, advancing a lead compound for ALS and Parkinson’s symptoms.</td>
  </tr>
  <tr>
    <td><a href="https://www.cuprina.com" target="_blank">Cuprina Holdings</a></td>
    <td>CUPR</td>
    <td>April 11, 2025</td>
    <td>$13.8M</td>
    <td><span class="badge">Bio wound-care</span></td>
    <td>Makes wound-care products that use sterile maggots to clean chronic wounds like diabetic foot ulcers. FDA cleared and already in use.</td>
  </tr>
  <tr>
    <td><a href="https://www.cardionova.com" target="_blank">CardioNova</a></td>
    <td>CDNV</td>
    <td>May 22, 2025</td>
    <td>$200M</td>
    <td><span class="badge">Cardiology</span></td>
    <td>Developing RNA-based treatments for heart failure and other chronic cardiovascular conditions.</td>
  </tr>
  <tr>
    <td><a href="https://www.hingehealth.com" target="_blank">Hinge Health</a></td>
    <td>HNGE</td>
    <td>May 22, 2025</td>
    <td>$437.3M</td>
    <td><span class="badge">Dimensional therapy</span></td>
    <td>Provides virtual care for joint and back pain using sensors, remote coaches, and a mobile app. It’s a digital alternative to in-person physical therapy.</td>
  </tr>
  <tr>
    <td><a href="https://www.omadahealth.com" target="_blank">Omada Health</a></td>
    <td>OMDA</td>
    <td>June 6, 2025</td>
    <td>~$150M</td>
    <td><span class="badge">Chronic care digital</span></td>
    <td>A digital platform for chronic conditions like diabetes and hypertension. Patients get coaching, devices, and app-based tracking to manage health remotely.</td>
  </tr>
  <tr>
    <td><a href="https://www.carisls.com" target="_blank">Caris Life Sciences</a></td>
    <td>CAI</td>
    <td>June 18, 2025</td>
    <td>$494M</td>
    <td><span class="badge">Cancer diagnostics</span></td>
    <td>Caris uses AI and molecular profiling (DNA, RNA, protein) to guide cancer treatment decisions. Doctors use it to match patients to targeted therapies.</td>
  </tr>
  <tr>
    <td><a href="https://www.genecure.com" target="_blank">GeneCure Therapeutics</a></td>
    <td>GNCR</td>
    <td>January 18, 2025</td>
    <td>$180M</td>
    <td><span class="badge">Rare Genetic Diseases</span></td>
    <td>IPO proceeds fund next-gen gene therapies for ultra-rare disorders with no approved treatments.</td>
  </tr>
</tbody>

        </table>
      </div>
    </div>
  </section>

  <!-- ✅ Footer -->
  <footer>
    <div class="container">
      <p>© 2025 Statmint. IPO data sourced from company filings and financial news. For reference only.</p>
      <p>Questions? <a href="mailto:info@statmint.org">Contact us</a></p>
    </div>
  </footer>

  <script src="https://unpkg.com/aos@2.3.4/dist/aos.js"></script>
  <script>
    AOS.init({
      duration: 1000,
      once: true,
      easing: 'ease-in-out'
    });
  </script>
</body>
</html>
